EU BUSINESS NEWS / German CEO Excellence Awards 2022 5 , and Cardiff, gaining notoriety as a front-runner in modern scientific advances related to cancer and cancer treatment. From 1992 to 1999, the Professor – a native of Sindelfingen originally – worked as an assistant doctor in a Surgical capacity at Ulm University Hospital. Using this experience as a springboard, he found his passion truly lay in finding new and better ways to help people struggling with tumours that would be just as good at reducing the growths as aggressive treatments without the added trauma of such therapies. He also has experience with heading up day clinics and research laboratories, working in the surgical clinic proper as a senior physician for two years, where he expanded on his already expansive knowledge of surgical oncology within chemotherapy and its follow-ups. In 1995, Professor Ganuage received the Fred Stephans Award, and the Merckle Research Award some four years on, publishing over 160 scientific journals and writing numerous book chapters during this time. Additionally, he has also become a reviewer for renowned scientific journals and a co-editor of Langenbeck’s Archives of Surgery, contributing to modern science in exemplary ways that have propelled LDG Laboratories and his own research into prominence. Hoping to continue to promote the effectiveness of and improve the processes within dendritic cell tumour therapies in the future, he hopes that he and his team will be able to provide this treatment for countless more individuals in the coming year. Working with diligence, tenacity, and respect, LDG Laboratories only hopes to help treat malignant tumours for all patients who require its help. Company: LDG Laboratories Dr Gansauge Contact: Frank Gansauge Website: labor-gansauge.de
RkJQdWJsaXNoZXIy MTUyMDQwMA==